K2M set the follow-on offering price at $18.75 per share.
Author: Staff
Baptist Health South Florida, based in Miami, has created an integrated orthopedics and sports medicine program.
Amedica announced the FDA has expanded the indications of its silicon nitride interbody fusion products to include multilevel cervical treatment.
Mazor Robotics announced the first transcerebellar brainstem biopsy using its Renaissance Guidance System has been successfully completed.
NuVasive's shares sank by 0.94 percent in the last week, according to an Ashburn Daily report.
Advertisement
Zacks restated their neutral rating on shares of Stryker in a new report, according to an Intercooler Online report.
OrthAlign received CE Mark approval to market its OrthAlign Plus system.
Baird upgraded Zimmer to "outperform" from "neutral," according to a Rock Hill Daily report.
The Dallas PRP and Stem Cell Center established a clinical institute offering treatments for patients with musculoskeletal injuries and conditions.
Silver Cross Hospital in New Lenox, Ill., added Aaron Kim, DPM, to its physician team, according to a report by The Herald-News.